Cytokines are systemic effectors of lymphatic function in acute inflammation

Cytokine

Volumn 64, Issue 1, 2013, Pages 362-369

  Aldrich, Melissa B ^a   Sevick Muraca, Eva M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Inflammation; Interleukin 1 beta; Interleukin 6; Lymphatic; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; INFLAMMATION; LYMPH FLOW; LYMPH VESSEL; LYMPHATIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

MURINAE;

CD14/TLR4/MD2; CD14/TOLL-LIKE RECEPTOR 4/MD2; ICG; IFN-Γ; IL; INDOCYANINE GREEN; INDUCIBLE NITRIC OXIDE; INFLAMMATION; INOS; INTERFERON-GAMMA; INTERLEUKIN; INTERLEUKIN-1 BETA; INTERLEUKIN-6; L-NIL; LECS; LIPOPOLYSACCHARIDE; LPS; LYMPHATIC; LYMPHATIC ENDOTHELIAL CELLS; MCP-1/CCL2; MONOCYTE CHEMOATTRACTANT PROTEIN-1/CHEMOKINE (C-C MOTIF) LIGAND 2; N-IMINOETHYL-L-LYSINE; NEAR-INFRARED FLUORESCENCE IMAGING; NIRF; T HELPER 1-TYPE; TH1-TYPE; TUMOR NECROSIS FACTOR-ALPHA;

ACUTE DISEASE; ANIMALS; CELLS, CULTURED; FEMALE; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; LYSINE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OPTICAL IMAGING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883551247     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.05.015     Document Type: Article

References (72)

1. Stedman T.L. Stedman's medical dictionary 2006, Lippincott Williams and Wilkins, Baltimore, Maryland. 28th ed.
2. Alitalo K. The lymphatic vasculature in disease. Nat Med 2011, 17:1371-1380.
3. Wang Y., Oliver G. Current views on the function of the lymphatic vasculature in health and disease. Gene Dev 2010, 24:2115-2126.
4. Kwon S., Sevick-Muraca E.M. Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol 2007, 5:219-231.
5. Rasmussen J.C., Tan I.-C., Marshall M.V., Adams K.E., Kwon S., Fife C.E., et al. Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence. Transl Oncol 2010, 3:362-372.
6. Aldrich M.B., Davies-Venn C., Angermiller B., Robinson H., Chan W., Kwon S., et al. Concentration of ICG does not significantly influence lymphatic function as assessed by near-infrared imaging. Lymphat Res Biol 2012, 10:1-6.
7. Schromm A.B., Howe J., Ulmer A.J., Wiesmuller K.H., Seyberth T., Jung G., et al. Physicochemical and biological analysis of synthetic bacterial lipopeptides: validity of the concept of endotoxic conformation. J Biol Chem 2007, 282:11030-11037.
8. Flister M.J., Wilber A., Hall K.L., Iwata C., Miyazono K., Nisato R.E., et al. Inflammation induces lymphangiogenesis through upregulation of VEGFR-2 mediated by NF-kB and Prox1. Blood 2010, 115:418-429.
9. Kang S., Lee S.-P., Kim K.E., Kim H.-Z., Memet S., Koh G.Y. Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages. Blood 2009, 113:2605-2613.
10. + macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009, 113:5650-5659.
11. Wilting J., Becker J., Buttler K., Weich H.A. Lymphatics and inflammation. Curr Med Chem 2009, 16:4581-4592.
12. Halin C., Detmar M. Inflammation, angiogenesis, and lymphangiogenesis. Method Enzymol 2008, 445:1-25. [Chapter 1].
13. Kim H., Kataru R.P., Koh G.Y. Regulation and implications of inflammatory lymphangiogenesis. Trends Immunol 2012, 33:350-356.
14. Lee K.M., McKimmie C.S., Gilchrist D.S., Pallas K.J., Nibbs R.J., Garside P., et al. D6 facilitates cellular migration, and fluid flow, to lymph nodes by suppressing lymphatic congestion. Blood 2011, 118:6220-6229.
15. Angeli V., Randolph G.J. Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol 2006, 4:217-228.
16. Elias R.M., Johnston M.G., Hayashi A., Nelson W. Decreased lymphatic pumping after intravenous endotoxin administration in sheep. Am J Physiol 1987, 253. H1349-57.
17. Wee J.L., Greenwood D.L., Han X., Scheerlinck J.P. Inflammatory cytokines IL-6 and TNF-alpha regulate lymphocyte trafficking through the local lymph node. Vet Immunol Immunopathol 2011, 144:95-103.
18. He C., Young A.J., West C.A., Su M., Konerding M.A., Mentzer S.J. Stimulation of regional lymphatic and blood flow by epicutaneous oxazolone. J Appl Physiol 2002, 93:966-973.
19. Worm A.N., Rossing D. Microvascular protein leakage in extensive skin diseases: aspects of the transport mechanisms. J Invest Dermatol 1980, 75:302-305.
20. Staberg B., Klemp P., Aasted M., Worm A.M., Lund P. Lymphatic albumin clearance from psoriatic skin. J Am Acad Dermatol 1989, 9:857-861.
21. Zhou Q., Wood R., Schwarz E.M., Wang Y.-J., Xing L. Near infrared lymphatic imaging demonstrates the dynamics of lymph flow and lymphangiogenesis during the acute vs. chronic phases of arthritis in mice. Arthritis Rheum 2010, 62:1881-1889.
22. von der Weid P.Y., Muthuchamy M. Regulatory mechanisms in lymphatic vessel contraction under normal and inflammatory conditions. Pathophysiol 2009, 17:263-276.
23. Gopee N.V., Cui Y., Olson G., Warbritton A.R., Miller B.J., Couch L.H., et al. Response of mouse skin to tattooing: use of SKH-1 mice as surrogate model for human tattooing. Toxicol Appl Pharmacol 2005, 209:145-158.
24. Daviaud D., Boucher J., Gesta S., Dray C., Guigne C., Quilliot D., et al. TNF-α up-regulates apelin expression in human and mouse adipose tissue. FASEB J 2006, 20:1528-1530.
25. Katagiri H., Ito Y., Ito S., Murata T., Yukihito S., Narumiya S., et al. TNF-alpha induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver. Shock 2008, 30:463-467.
26. Croker B.A., Krebs D.L., Zhang J.-G., Wormald S., Willson T.A., Stanley E.G., et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 2003, 4:540-545.
27. Bethin K.E., Vogt S.K., Muglia L.J. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. PNAS 2000, 97:9317-9322.
28. Campbell J.S., Prichard L., Schaper F., Schmitz J., Stephenson-Famy A., et al. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest 2000, 107:1285-1292.
29. Kimura H., Ishibashi T., Shikama Y., Okano A., Akiyama Y., Uchida T., et al. Interleukin-1 beta (IL-1 beta) induces thrombocytosis in mice: possible implication of IL-6. Blood 1990, 76:2493-2500.
30. Bani M.R., Garofalo A., Scanziani E., Giavazzi R. Effect of interleukin-1-beta on metastasis formation in different tumor systems. J Natl Cancer Inst 1991, 83:119-123.
31. Tong Y., Tucker S.B. Normal mouse skin lymphocyte, Langerhans cell, and keratinocyte responses to intradermal injections of interferon-alpha and interferon-gamma. J Interferon Cytokine Res 1995, 15:235-241.
32. Suda T., Callahan R.J., Wilkenson R.A., van Rooijen N., Scheeberger E.E. Interferon-γ reduces 1a+ dendritic cell traffic to the lung. J Leukocyte Biol 1996, 60:519-526.
33. Rutenfranz I., Kirchner H. Pharmacokinetics of recombinant murine interferon-gamma in mice. J Interferon Res 1988, 8:573-580.
34. Kim H.S., Chung D.H. TLR4-mediated IL-12 production enhances IFN-γ and IL-1β, which inhibits TGF-β production and promotes antibody-induced joint inflammation. Arthritis Res Ther 2012, 14. R210-22.
35. Maus U., Huwe J., Maus R., Seeger W., Lohmeyer J. Alveolar JE/MCP-1 and endotoxin synergize to provoke lung cytokine upregulation, sequential neutrophil and monocyte influx, and vascular leakage in mice. Am J Respir Crit Care Med 2001, 164:406-411.
36. Wang H., Peters T., Kess D., Sindrilaru A., Oreshkova T., Rooijen N.V., et al. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 2006, 116:2105-2114.
37. 4. J Immunol 1999, 163:6148-6154.
38. Lee W.Y., Lockniskar M.F., Fischer S.M. Interleukin-1α mediates phorbol ester-induced inflammation and epidermal hyperplasia. FASEB J 1994, 8:1081-1087.
39. Johnson C.S., Keckler D.J., Topper M.I., Braunschweiger P.G., Furmanski P. In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood 1989, 73:678-683.
40. Czuprynski D.J., Brown J.F. Recombinant murine interleukin-1 alpha enhancement of nonspecific antibacterial resistance. Infect Immun 1987, 55:2061-2065.
41. Wright K., Morgan E.T. Regulation of cytochrome P450IIC12 expression by interleukin-1 alpha, interleukin-6, and dexamethasone. Mol Pharmacol 1991, 39:468-474.
42. Uzarski J., Drelles M.B., Gibbs S.E., Ongstad E.L., Goral J.C., McKeown K.K., et al. The resolution of lymphedema by interstitial flow in the mouse tail skin. Am J Physiol Heart Circ Physiol 2008, 294. H1326-34.
43. Gao B., Wang Y., Tsan M.-F. The heat sensitivity of cytokine-inducing effect of lipopolysaccharide. J Leukocyte Biol 2006, 80:359-366.
44. Majde J.A. Endotoxin detection. Immunol Today 1992, 13:328-329.
45. Schwager I., Jungi T.W. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 1994, 83:152-160.
46. Kaye S.A., Louise C.B., Boyd B., Lingwood C.A., Obrig T.G. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shig toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun 1993, 61:3886-3891.
47. Chaitanya G.V., Franks S.E., Cromer W., Wells S.R., Bienkowska M., Jennings M.H., et al. Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro. Lymphat Res Biol 2010, 8:155-164.
48. Williams M.R., Kataoka N., Sakurai Y., Powers C.M., Eskin S.G., McIntire L.V. Gene expression of endothelial cells due to interleukin-1 beta stimulation and neutrophil transmigration. Endothelium 2008, 15:73-165.
49. Ni C.W., Hsieh H.J., Chao Y.J., Wang D.L. Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow. Am J Physiol Cell Physiol 2004, 287. C771-80.
50. Dyson A., Bryan N.S., Fernandez B.O., Garcia-Saura M.-R., Saijo F., Mongardon N., et al. An integrated approach to assessing nitroso-redox balance in systemic inflammation. Free Radical Biol Med 2011, 51:1137-1145.
51. Ju T.J., Dan J.M., Cho Y.J., Park S.Y. Inhibition of inducible nitric oxide synthase attenuates monosodium urate-induced inflammation in mice. Korean J Physiol Pharmacol 2011, 15:363-369.
52. Granger D.N., Senchenkova E. Inflammation and the microcirculation 2010, Morgan & Claypool Publishers, San Rafael (California), [Chapter 4].
53. Schmid-Schonbein G.W. Nitric oxide (NO) side of lymphatic flow and immune surveillance. Proc Natl Acad Sci USA 2012, 109:3-4.
54. Marchetti C., Casasco A., Di Nucci A., Reguzzoni M., Rosso S., Piovella F., et al. Endothelin and nitric oxide synthase in lymphatic endothelial cells: immunolocalization in vivo and in vitro. Anat Rec 1997, 248:490-497.
55. Hagendoorn J., Padera T.P., Kashiwagi S., Isaka N., Noda F., Lin M.I., et al. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ Res 2004, 95:204-209.
56. Triggle C.R., Samuel S.M., Ravishankar S., Marei I., Arunachalam G., Ding H. The endothelium: influencing vascular smooth muscle in many ways. Can J Physiol Pharmacol 2012, 90:713-738.
57. Sawa Y., Ueki T., Hata M., Iwasawa K., Tsuruga E., Kojima H., et al. LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J Histochem Cytochem 2008, 56:97-109.
58. Garrafa E., Imberti L., Tiberio G., Prandini A., Giulini S.M., Caimi L. Heterogeneous expression of toll-like receptors in lymphatic endothelial cells derived from different tissues. Immunol Cell Biol 2011, 89:475-481.
59. Chakraborty S., Nepiyushchikh Z., Davis M.J., Zawieja D.C., Muthuchamy M. Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R. Microcirculation 2011, 18:24-35.
60. Lobov G.I., Pan'kova M.N. Heparin inhibits contraction of smooth muscle cells in lymphatic vessels. Bull Exp Biol Med 2010, 149:4-6.
61. von der Weid P.Y., Rehal S., Dyrda P., Lee S., Mathias R., Rahman M., et al. Mechanisms of VIP-induced inhibition of the lymphatic vessel pump. J Physiol 2012, 590:2677-2691.
62. Muthuchamy M., Zawieja D. Molecular Regulation of Lymphatic Contractility. Ann NY Acad Sci 2008, 1131:89-99.
63. Lukacs-Kornek V., Malhotra D., Fletcher A.L., Acton S.E., Elpek K.G., Tayalia P., et al. Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat Immunol 2012, 12:1096-1104.
64. Bohlen H.G., Gasheva O.Y., Zawieja D.C. Nitric oxide formation by lymphatic bulb and valves is a major regulatory component of lymphatic pumping. Am J Physiol Heart Circ Physiol 2011, 301. H1897-906.
65. von der Weid P.Y., Zhao J., van Helden D.F. Nitric oxide decreases pacemaker activity in lymphatic vessels of guinea pig mesentery. Am J Physiol Heart Circ Physiol 2001, 280. H2707-16.
66. Lewis R.S., Kolesnik T.B., Kuang Z., D'Cruz A.A., Blewitt M.E., Masters S.L., et al. TLR regulation of SPSB1 controls inducible nitric oxide synthase induction. J Immunol 2011, 187:3798-3805.
67. Kunder C.A., John A.L., Li G., Leong K.W., Berwin B., Staats H.F., et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med 2009, 206:2455-2467.
68. Soderberg K.A., Payne G.W., Sato A., Medzhitov R., Segal S.S., Iwasaki A. Innate control of adaptive immunity via remodeling of lymph node feed arteriole. PNAS 2005, 102:16315-16320.
69. Liao S., Cheng G., Conner D.A., Huang Y., Kucherlapati R.S., Munn L.L., et al. Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci USA 2011, 108:18784-18789.
70. Margaris K.N., Black R.A. Modelling the lymphatic system: challenges and opportunities. J R Soc Interface 2012, 9:601-612.
71. Aldrich M.B., Guilliod R., Fife C.E., Maus E.A., Smith L., Rasmussen J.C., et al. Lymphatic abnormalities in the normal contralateral arms of subjects with breast cancer-related lymphedema as assessed by near-infrared fluorescent imaging. Biomedical Optics Express 2012, 3:1256-1265.
72. Mellor R.H., Stanton A.W., Azarbod P., Sherman M.D., Levick J.R., Mortimer P.S. Enhanced cutaneous lymphatic network in the forearms of women with postmastectomy oedema. J Vasc Res 2000, 37:501-512.